GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Suzuken Co Ltd (TSE:9987) » Definitions » Debt-to-Equity

Suzuken Co (TSE:9987) Debt-to-Equity : 0.00 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Suzuken Co Debt-to-Equity?

Suzuken Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円0 Mil. Suzuken Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円0 Mil. Suzuken Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was 円410,845 Mil. Suzuken Co's debt to equity for the quarter that ended in Dec. 2023 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Suzuken Co's Debt-to-Equity or its related term are showing as below:

During the past 13 years, the highest Debt-to-Equity Ratio of Suzuken Co was 0.01. The lowest was 0.00. And the median was 0.00.

TSE:9987's Debt-to-Equity is not ranked *
in the Medical Distribution industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

Suzuken Co Debt-to-Equity Historical Data

The historical data trend for Suzuken Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzuken Co Debt-to-Equity Chart

Suzuken Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Suzuken Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Suzuken Co's Debt-to-Equity

For the Medical Distribution subindustry, Suzuken Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzuken Co's Debt-to-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Suzuken Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Suzuken Co's Debt-to-Equity falls into.



Suzuken Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Suzuken Co's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Suzuken Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzuken Co  (TSE:9987) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Suzuken Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Suzuken Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzuken Co (TSE:9987) Business Description

Traded in Other Exchanges
N/A
Address
8 Higashi Kataha-machi, Higashi-ku, Nagoya, JPN, 461-8701
Suzuken Co Ltd is a Japanese drug manufacturer. It functions through four segments: Pharmaceutical Wholesale, which sells pharmaceuticals, diagnostic drugs, and medical equipment and materials; The Pharmaceutical Manufacturing, which produces pharmaceuticals and diagnostic drugs; The Insurance Pharmacy dispenses operations based on prescriptions from medical institutions and the Medical-related Service and Others segment which sells medical books, provides nursing services and manufactures physiological examination equipment.

Suzuken Co (TSE:9987) Headlines

No Headlines